[Abdominal CT: role of a gas reducing drug (author's transl)].
D000934:Antifoaming Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007422:Intestines / Q000000981:diagnostic imaging; D008297:Male; D010194:Pancreatin / Q000627:therapeutic use*; D011506:Proteins / Q000627:therapeutic use*; D011860:Radiography, Abdominal; D012828:Silicones / Q000627:therapeutic use*; D012841:Simethicone / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D000934:Antifoaming Agents; D004338:Drug Combinations; D011506:Proteins; D012828:Silicones; D013501:Surface-Active Agents; C029042:Pereflat; D010194:Pancreatin; D012841:Simethicone
Etude scanographique clinique abdominale: intérêt d'un antimétérique.